Jefferies Group LLC Forte Biosciences, Inc. Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

Shares

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 14, 2022	SELL	$2.02 - $3.36 $64,438 - $107,184	-31,900 Closed	0 $0
Q3 2021 Sep 21, 2023	BUY	$2.96 - $36.67 $94,424 - $1.17 Million	31,900 New	31,900 $94,000
Q3 2021 Nov 15, 2021	BUY	$2.96 - $36.67 $94,424 - $1.17 Million	31,900 New	31,900 $94,000

Others Institutions Holding FBRX

# of Institutions

1

Shares Held

175K

Call Options Held

0

Put Options Held

0

Black Rock Inc. New York, NY

175K
Shares

$977,456
0.0% of portfolio

About Forte Biosciences, Inc.

Ticker FBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,340,300
Market Cap $114M
Description
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

More about FBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.